Back to search
FDAFDA · Food and drugs·Recall number D-0402-2025

Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Mehsana, India, , Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 NDC 70121-1734-1 (bag); NDC 70121-1734-3 (box)

Published May 14, 2025 · Recall initiated: April 17, 2025

Summary

FDA records drug Class I recall D-0402-2025, published May 14, 2025 and initiated April 17, 2025. Recalling firm: Amneal Pharmaceuticals, LLC; Status: Ongoing; Reported quantity: 62 (12x100mL) bags; Lot: Lot #'s: AL240003, AL240004, Exp.: 01/31/2026. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter

What to do

Voluntary: Firm initiated · Letter

Get an email if ROPIVACAINE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ROPIVACAINE HYDROCHLORIDE
Manufacturer
Amneal Pharmaceuticals, LLC
Distributor
Nationwide in the US
UPC
0370121173533
Lot
Lot #'s: AL240003, AL240004, Exp.: 01/31/2026
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Mehsana, India, , Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 NDC 70121-1734-1 (bag); NDC 70121-1734-3 (box) recalled?

Yes. FDA published recall D-0402-2025 on May 14, 2025. Reported hazard: Presence of Particulate Matter

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ROPIVACAINE HYDROCHLORIDE. UPC: 0370121173533.